The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Shared and Distinct Aspects of the Sepsis Transcriptomic Response to Fecal Peritonitis and Pneumonia
Open accessAbstract
RATIONALE: Heterogeneity in the septic response has hindered efforts to understand pathophysiology and develop targeted therapies. Source of infection, with different causative organisms and temporal changes, might influence this heterogeneity. OBJECTIVES: To investigate individual and temporal variations in the transcriptomic response to sepsis due to fecal peritonitis, and to compare these with the same parameters in community-acquired pneumonia. METHODS: We performed genome-wide gene expression profiling in peripheral blood leukocytes of adult patients admitted to intensive care with sepsis due to fecal peritonitis (n = 117) or community-acquired pneumonia (n = 126), and of control subjects without sepsis (n = 10). MEASUREMENTS AND MAIN RESULTS: A substantial portion of the transcribed genome (18%) was differentially expressed compared with that of control subjects, independent of source of infection, with eukaryotic initiation factor 2 signaling being the most enriched canonical pathway. We identified two sepsis response signature (SRS) subgroups in fecal peritonitis associated with early mortality (P = 0.01; hazard ratio, 4.78). We defined gene sets predictive of SRS group, and serial sampling demonstrated that subgroup membership is dynamic during intensive care unit admission. We found that SRS is the major predictor of transcriptomic variation; a small number of genes (n = 263) were differentially regulated according to the source of infection, enriched for IFN signaling and antigen presentation. We define temporal changes in gene expression from disease onset involving phagosome formation as well as natural killer cell and IL-3 signaling. CONCLUSIONS: The majority of the sepsis transcriptomic response is independent of the source of infection and includes signatures reflecting immune response state and prognosis. A modest number of genes show evidence of specificity. Our findings highlight opportunities for patient stratification and precision medicine in sepsis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The third international consensus definitions for sepsis and septic shock (Sepsis-3).
Singer, M., Deutschman, C. S., Seymour, C. W., Shankar-Hari, M., Annane, D., Bauer, M., Bellomo, R., Bernard, G. R., Chiche, J.-D., Coopersmith, C. M., et al. (2016) · JAMA · doi:10.1001/jama.2016.0287 · Cited by 28,250
Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy
Hotchkiss, R. S., Monneret, G., & Payen, D. (2013) · Nature Reviews Immunology · doi:10.1038/nri3552 · Cited by 2,772 · cited 3×
“Our analysis, coupled with recent advances in the field (3, 4, 11, 41), highlights the opportunity to develop novel therapeutic interventions that can be targeted and appropriately timed to individual patients on the basis of their transcriptomic signatures, providing opportunities for precision medicine in sepsis.”
Huber, W., von Heydebreck, A., Sültmann, H., Poustka, A., & Vingron, M. (2002) · Bioinformatics · doi:10.1093/bioinformatics/18.suppl_1.s96 · Cited by 2,440
Why have clinical trials in sepsis failed?
Marshall, J. C. (2014) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2014.01.007 · Cited by 805
Characteristics and outcomes of culture-negative versus culture-positive severe sepsis.
Phua, J., Ngerng, W. J., See, K. C., Tay, C. K., Kiong, T., Lim, H. F., Chew, M. Y., Yip, H. S., Tan, A., Khalizah, H. J., et al. (2013) · Critical Care · doi:10.1186/cc12896 · Cited by 382
Sweeney, T. E., Wong, H. R., & Khatri, P. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aaf7165 · Cited by 334
Cited by
The immunopathology of sepsis and potential therapeutic targets
van der Poll, T., van de Veerdonk, F. L., Scicluna, B. P., & Netea, M. G. (2017) · Nature Reviews Immunology · doi:10.1038/nri.2017.36 · Cited by 1,957
van der Poll, T., Shankar-Hari, M., & Wiersinga, W. J. (2021) · Immunity · doi:10.1016/j.immuni.2021.10.012 · Cited by 1,010
Prognostic and predictive enrichment in sepsis
Stanski, N. L., & Wong, H. R. (2020) · Nature Reviews Nephrology · doi:10.1038/s41581-019-0199-3 · Cited by 393
Antcliffe, D. B., Burnham, K. L., Al-Beidh, F., Santhakumaran, S., Brett, S. J., Hinds, C. J., Ashby, D., Knight, J. C., & Gordon, A. C. (2019) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201807-1419oc · Cited by 365
Self-citationSweeney, T. E., Azad, T. D., Donato, M., Haynes, W. A., Perumal, T. M., Henao, R., Bermejo-Martin, J. F., Almansa, R., Tamayo, E., Howrylak, J. A., et al. (2018) · Critical Care Medicine · doi:10.1097/ccm.0000000000003084 · Cited by 362
Metadata
- Authors
- Burnham, K. L., Davenport, E. E., Radhakrishnan, J., Humburg, P., Gordon, A. C., Hutton, P., Svoren-Jabalera, E., Garrard, C., Hill, A. V. S., Hinds, C. J., & Knight, J. C.
- Venue
- American Journal of Respiratory and Critical Care Medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 2017-08-01
- Volume
- 196
- Issue
- 3
- Pages
- 328-339
- ISSN
- 1073-449X (ISSN-L)
- 1535-4970
- OpenAlex
- W2586512179
- Cited by
- 249
- References
- 6
- FWCI
- 14.47
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Shared and Distinct Aspects of the Sepsis Transcriptomic Response to Fecal Peritonitis and Pneumonia. https://app.cochat.ai/papers/10.1164/rccm.201608-1685oc
- The paper
- Burnham, K. L., Davenport, E. E., Radhakrishnan, J., Humburg, P., Gordon, A. C., Hutton, P., Svoren-Jabalera, E., Garrard, C., Hill, A. V. S., Hinds, C. J., & Knight, J. C. (2017). Shared and Distinct Aspects of the Sepsis Transcriptomic Response to Fecal Peritonitis and Pneumonia. American Journal of Respiratory and Critical Care Medicine. https://doi.org/10.1164/rccm.201608-1685oc
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.